Development of natural product-based targeted protein degraders as anticancer agents

被引:5
作者
Chen, Cheng [1 ]
Feng, Yanyan [1 ]
Zhou, Chen [3 ]
Liu, Zhouyan [1 ]
Tang, Ziwei [1 ]
Zhang, Ye [2 ]
Li, Tong [1 ]
Gu, Chenglei [1 ]
Chen, Jichao [1 ]
机构
[1] Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210023, Peoples R China
[2] Changzhou Univ, Sch Petrochem Engn, Changzhou 213164, Peoples R China
[3] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA
基金
中国国家自然科学基金;
关键词
Natural product; PROTAC; Molecular glue; Hydrophobic tagging; Anticancer; PSEUDOLARIC ACID B; CELL-CYCLE; QUALITY-CONTROL; ANTITUMOR-ACTIVITY; SMALL MOLECULES; DRUG DISCOVERY; DEGRADATION; CANCER; PROTAC; STAT3;
D O I
10.1016/j.bioorg.2024.107772
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeted protein degradation (TPD) has emerged as a powerful approach for eliminating cancer-causing proteins through an "event-driven" pharmacological mode. Proteolysis-targeting chimeras (PROTACs), molecular glues (MGs), and hydrophobic tagging (HyTing) have evolved into three major classes of TPD technologies. Natural products (NPs) are a primary source of anticancer drugs and have played important roles in the development of TPD technology. NPs potentially expand the toolbox of TPD by providing a variety of E3 ligase ligands, protein of interest (POI) warheads, and hydrophobic tags (HyTs). As a promising direction in the TPD field, NP-based degraders have shown great potential for anticancer therapy. In this review, we summarize recent advances in the development of NP-based degraders (PROTACs, MGs and HyTing) with anticancer applications. Moreover, we put forward the challenges while presenting potential opportunities for the advancement of future targeted protein degraders derived from NPs.
引用
收藏
页数:18
相关论文
共 202 条
[31]  
Huynh DL, 2017, CHIN J NAT MEDICINES, V15, P15, DOI 10.1016/S1875-5364(17)30005-5
[32]   Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery [J].
Dong, Guoqiang ;
Ding, Yu ;
He, Shipeng ;
Sheng, Chunquan .
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) :10606-10620
[33]   The Antitumor Activity of Piplartine: A Review [J].
Duarte, Allana Brunna S. ;
Gomes, Rebeca C. ;
Nunes, Vitoria Regina V. ;
Goncalves, Juan Carlos R. ;
Correia, Camylla A. ;
dos Santos, Ana Zulmira G. ;
de Sousa, Damiao P. .
PHARMACEUTICALS, 2023, 16 (09)
[34]   Nature's Chemists: The Discovery and Engineering of Phytochemical Biosynthesis [J].
Eljounaidi, Kaouthar ;
Lichman, Benjamin R. .
FRONTIERS IN CHEMISTRY, 2020, 8
[35]   Limonoids From the Genus Melia (Meliaceae): Phytochemistry, Synthesis, Bioactivities, Pharmacokinetics, and Toxicology [J].
Fan, Wenxiang ;
Fan, Linhong ;
Wang, Zhengtao ;
Yang, Li .
FRONTIERS IN PHARMACOLOGY, 2022, 12
[36]   Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer [J].
Favorskaya, Irina ;
Kainov, Yaroslav ;
Chemeris, Galina ;
Komelkov, Andrei ;
Zborovskaya, Irina ;
Tchevkina, Elena .
TUMOR BIOLOGY, 2014, 35 (10) :10295-10300
[37]   Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide [J].
Fischer, Eric S. ;
Boehm, Kerstin ;
Lydeard, John R. ;
Yang, Haidi ;
Stadler, Michael B. ;
Cavadini, Simone ;
Nagel, Jane ;
Serluca, Fabrizio ;
Acker, Vincent ;
Lingaraju, Gondichatnahalli M. ;
Tichkule, Ritesh B. ;
Schebesta, Michael ;
Forrester, William C. ;
Schirle, Markus ;
Hassiepen, Ulrich ;
Ottl, Johannes ;
Hild, Marc ;
Beckwith, Rohan E. J. ;
Harper, J. Wade ;
Jenkins, Jeremy L. ;
Thomae, Nicolas H. .
NATURE, 2014, 512 (7512) :49-+
[38]   Exposed hydrophobicity is a key determinant of nuclear quality control degradation [J].
Fredrickson, Eric K. ;
Rosenbaum, Joel C. ;
Locke, Melissa N. ;
Milac, Thomas I. ;
Gardner, Richard G. .
MOLECULAR BIOLOGY OF THE CELL, 2011, 22 (13) :2384-2395
[39]   Thymoquinone: A promising anti-cancer drug from natural sources [J].
Gali-Muhtasib, Hala ;
Roessner, Albert ;
Schneider-Stock, Regine .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (08) :1249-1253
[40]   Hydrophobic Tag Tethering Degradation, The Emerging Targeted Protein Degradation Strategy [J].
Gao, Jieke ;
Zhang, Jiantao ;
Han, Xiaoli ;
Zhou, Jinming .
CURRENT MEDICINAL CHEMISTRY, 2023, 30 (27) :3137-3155